Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Abstract:

BACKGROUND:In the acute phase of infection with feline immunodeficiency virus (FIV), the virus targets activated CD4+ T cells by utilising CD134 (OX40) as a primary attachment receptor and CXCR4 as a co-receptor. The nature of the virus-receptor interaction varies between isolates; strains such as GL8 and CPGammer recognise a "complex" determinant on CD134 formed by cysteine-rich domains (CRDs) 1 and 2 of the molecule while strains such as PPR and B2542 require a more "simple" determinant comprising CRD1 only for infection. These differences in receptor recognition manifest as variations in sensitivity to receptor antagonists. In this study, we ask whether the nature of the virus-receptor interaction evolves in vivo. RESULTS:Following infection with a homogeneous viral population derived from a pathogenic molecular clone, a quasispecies emerged comprising variants with distinct sensitivities to neutralising antibody and displaying evidence of conversion from a "complex" to a "simple" interaction with CD134. Escape from neutralising antibody was mediated primarily by length and sequence polymorphisms in the V5 region of Env, and these alterations in V5 modulated the virus-receptor interaction as indicated by altered sensitivities to antagonism by both anti-CD134 antibody and soluble CD134. CONCLUSIONS:The FIV-receptor interaction evolves under the selective pressure of the host humoral immune response, and the V5 loop contributes to the virus-receptor interaction. Our data are consistent with a model whereby viruses with distinct biological properties are present in early versus late infection and with a shift from a "complex" to a "simple" interaction with CD134 with time post-infection.

journal_name

Retrovirology

journal_title

Retrovirology

authors

Willett BJ,Kraase M,Logan N,McMonagle EL,Samman A,Hosie MJ

doi

10.1186/1742-4690-7-38

subject

Has Abstract

pub_date

2010-04-26 00:00:00

pages

38

issn

1742-4690

pii

1742-4690-7-38

journal_volume

7

pub_type

杂志文章
  • Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.

    abstract:BACKGROUND:HIV-1 replication is critically dependent upon controlled processing of its RNA and the activities provided by its encoded regulatory factors Tat and Rev. A screen of small molecule modulators of RNA processing identified several which inhibited virus gene expression, affecting both relative abundance of spe...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-017-0330-0

    authors: Balachandran A,Wong R,Stoilov P,Pan S,Blencowe B,Cheung P,Harrigan PR,Cochrane A

    更新日期:2017-01-26 00:00:00

  • Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

    abstract:BACKGROUND:Emergence of drug-resistant strains of human immunodeficiency virus type 1 (HIV-1) is a major obstacle to successful antiretroviral therapy (ART) in HIV-infected patients. Whether antiviral immunity can augment ART by suppressing replication of drug-resistant HIV-1 in humans is not well understood, but can b...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-97

    authors: Metzner KJ,Binley JM,Gettie A,Marx P,Nixon DF,Connor RI

    更新日期:2006-12-21 00:00:00

  • The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.

    abstract:BACKGROUND:The process of HIV-1 genomic RNA (gRNA) encapsidation is governed by a number of viral encoded components, most notably the Gag protein and gRNA cis elements in the canonical packaging signal (ψ). Also implicated in encapsidation are cis determinants in the R, U5, and PBS (primer binding site) from the 5' un...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-8-51

    authors: Cockrell AS,van Praag H,Santistevan N,Ma H,Kafri T

    更新日期:2011-06-24 00:00:00

  • Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms.

    abstract:BACKGROUND:A nef gene is present in all primate lentiviral genomes and is important for high viral loads and progression to AIDS in human or experimental macaque hosts of HIV or SIV, respectively. In these hosts, infection of the thymus results in a decreased output of naive T cells that may contribute to the developme...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-137

    authors: Van Nuffel A,Ariën KK,Stove V,Schindler M,O'Neill E,Schmökel J,Van de Walle I,Naessens E,Vanderstraeten H,Van Landeghem K,Taghon T,Pulkkinen K,Saksela K,Garcia JV,Fackler OT,Kirchhoff F,Verhasselt B

    更新日期:2013-11-15 00:00:00

  • HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

    abstract:BACKGROUND:Eradication of HIV cannot be achieved with combination antiretroviral therapy (cART) because of the persistence of long-lived latently infected resting memory CD4(+) T cells. We previously reported that HIV latency could be established in resting CD4(+) T cells in the presence of the chemokine CCL19. To defi...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-016-0284-7

    authors: Saleh S,Lu HK,Evans V,Harisson D,Zhou J,Jaworowski A,Sallmann G,Cheong KY,Mota TM,Tennakoon S,Angelovich TA,Anderson J,Harman A,Cunningham A,Gray L,Churchill M,Mak J,Drummer H,Vatakis DN,Lewin SR,Cameron PU

    更新日期:2016-07-26 00:00:00

  • Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.

    abstract:BACKGROUND:The widespread use of highly effective, combination antiretroviral therapy (cART) has led to a significant reduction in the incidence of HIV-associated dementia (HAD). Despite these advances, the prevalence of HIV-1 associated neurocognitive disorders (HANDs) has been estimated at approximately 40%-50%. In t...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0065-0

    authors: Evering TH,Kamau E,St Bernard L,Farmer CB,Kong XP,Markowitz M

    更新日期:2014-08-15 00:00:00

  • 'Libyan Trial': a verdict running counter to scientific evidence.

    abstract::Sidaction's appeal regarding the sentencing of medical personnels in the Libyan-HIV infection cases. ...

    journal_title:Retrovirology

    pub_type: 社论

    doi:10.1186/1742-4690-3-98

    authors: Fleutelot E

    更新日期:2006-12-27 00:00:00

  • Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.

    abstract::In order to characterize the antiviral activity of human TRIM5alpha in more detail human derived indicator cell lines over expressing wild type human TRIM5alpha were generated and challenged with HIV-1 and HIV-2 viruses pseudotyped with HIV envelope proteins in comparison to VSV-G pseudotyped particles. HIV envelope p...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-79

    authors: Kaumanns P,Hagmann I,Dittmar MT

    更新日期:2006-11-06 00:00:00

  • A purine-rich element in foamy virus pol regulates env splicing and gag/pol expression.

    abstract:BACKGROUND:The foamy viral genome encodes four central purine-rich elements localized in the integrase-coding region of pol. Previously, we have shown that the first two of these RNA elements (A and B) are required for protease dimerization and activation. The D element functions as internal polypurine tract during rev...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-017-0337-6

    authors: Moschall R,Denk S,Erkelenz S,Schenk C,Schaal H,Bodem J

    更新日期:2017-02-06 00:00:00

  • Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis.

    abstract:BACKGROUND:Certain murine leukemia viruses (MLVs) are capable of inducing progressive spongiform motor neuron disease in susceptible mice upon infection of the central nervous system (CNS). The major CNS parenchymal target of these neurovirulent retroviruses (NVs) are the microglia, whose infection is largely coinciden...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-26

    authors: Dimcheff DE,Volkert LG,Li Y,DeLucia AL,Lynch WP

    更新日期:2006-05-12 00:00:00

  • Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

    abstract:BACKGROUND:The gut-associated lymphoid tissue (GALT) is the largest lymphoid organ infected by human immunodeficiency virus type 1 (HIV-1). It serves as a viral reservoir and host-pathogen interface in infection. This study examined whether different parts of the gut and peripheral blood lymphocytes (PBL) contain diffe...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-7-74

    authors: van Marle G,Church DL,Nunweiler KD,Cannon K,Wainberg MA,Gill MJ

    更新日期:2010-09-13 00:00:00

  • The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.

    abstract:BACKGROUND:HIV-1 Integrase (IN) interacts with the cellular co-factor LEDGF/p75 and tethers the HIV preintegration complex to the host genome enabling integration. Recently a new class of IN inhibitors was described, the IN-LEDGF allosteric inhibitors (INLAIs). Designed to interfere with the IN-LEDGF interaction during...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-017-0373-2

    authors: Amadori C,van der Velden YU,Bonnard D,Orlov I,van Bel N,Le Rouzic E,Miralles L,Brias J,Chevreuil F,Spehner D,Chasset S,Ledoussal B,Mayr L,Moreau F,García F,Gatell J,Zamborlini A,Emiliani S,Ruff M,Klaholz BP,Moog C

    更新日期:2017-11-09 00:00:00

  • No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.

    abstract:BACKGROUND:Xenotropic murine leukemia virus (MLV)-related virus (XMRV) was initially identified in prostate cancer (PCa) tissue, particularly in the prostatic stromal fibroblasts, of patients homozygous for the RNASEL R462Q mutation. A subsequent study reported XMRV antigens in malignant prostatic epithelium and associ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-8-23

    authors: Sakuma T,Hué S,Squillace KA,Tonne JM,Blackburn PR,Ohmine S,Thatava T,Towers GJ,Ikeda Y

    更新日期:2011-03-29 00:00:00

  • Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

    abstract:BACKGROUND:Upon HIV entry into target cells, viral cores are released and rearranged into reverse transcription complexes (RTCs), which support reverse transcription and also protect and transport viral cDNA to the site of integration. RTCs are composed of viral and cellular proteins that originate from both target and...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-65

    authors: Santos S,Obukhov Y,Nekhai S,Bukrinsky M,Iordanskiy S

    更新日期:2012-08-13 00:00:00

  • Induction of p21(CIP1/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization.

    abstract::HTLV-1 Tax can induce senescence by up-regulating the levels of cyclin-dependent kinase inhibitors p21(CIP1/WAF1) and p27(KIP1). Tax increases p27(KIP1) protein stability by activating the anaphase promoting complex/cyclosome (APC/C) precociously, causing degradation of Skp2 and inactivation of SCF(Skp2), the E3 ligas...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-6-35

    authors: Zhang L,Zhi H,Liu M,Kuo YL,Giam CZ

    更新日期:2009-04-08 00:00:00

  • An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

    abstract:BACKGROUND:Entry of human immunodeficiency virus type 1 (HIV-1) into the host cell involves interactions between the viral envelope glycoproteins (Env) and the cellular receptor CD4 as well as a coreceptor molecule (most importantly CCR5 or CXCR4). Viral preference for a specific coreceptor (tropism) is in particular d...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-60

    authors: Bozek K,Eckhardt M,Sierra S,Anders M,Kaiser R,Kräusslich HG,Müller B,Lengauer T

    更新日期:2012-07-25 00:00:00

  • Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients.

    abstract:BACKGROUND:Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-5-7

    authors: Kapoor A,Shapiro B,Shafer RW,Shulman N,Rhee SY,Delwart EL

    更新日期:2008-01-25 00:00:00

  • DBR1 siRNA inhibition of HIV-1 replication.

    abstract:BACKGROUND:HIV-1 and all retroviruses are related to retroelements of simpler organisms such as the yeast Ty elements. Recent work has suggested that the yeast retroelement Ty1 replicates via an unexpected RNA lariat intermediate in cDNA synthesis. The putative genomic RNA lariat intermediate is formed by a 2'-5' phosp...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-2-63

    authors: Ye Y,De Leon J,Yokoyama N,Naidu Y,Camerini D

    更新日期:2005-10-18 00:00:00

  • The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.

    abstract:BACKGROUND:Integration of retroviral DNA into a germ cell can result in a provirus that is transmitted vertically to the host's offspring. In humans, such endogenous retroviruses (HERVs) comprise >8% of the genome. The HERV-K(HML-2) proviruses consist of ~90 elements related to mouse mammary tumor virus, which causes b...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0062-3

    authors: Wildschutte JH,Ram D,Subramanian R,Stevens VL,Coffin JM

    更新日期:2014-08-12 00:00:00

  • Memories of John N. Brady: scientist, mentor and friend.

    abstract::Friends and colleagues remember John N. Brady, Ph.D., Chief of the Virus Tumor Biology Section of the Laboratory of Cellular Oncology, who died much too young at the age of 57 on April 27, 2009 of colon cancer. John grew up in Illinois and received his Ph.D. with Dr. Richard Consigli at Kansas State University studyin...

    journal_title:Retrovirology

    pub_type: 传,社论,历史文章

    doi:10.1186/1742-4690-6-48

    authors: Pise-Masison CA,Marriott SJ

    更新日期:2009-05-19 00:00:00

  • Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

    abstract:BACKGROUND:We previously demonstrated that primary Th1Th17 cells are highly permissive to HIV-1, whereas Th1 cells are relatively resistant. Molecular mechanisms underlying these differences remain unknown. RESULTS:Exposure to replication competent and single-round VSV-G pseudotyped HIV strains provide evidence that s...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-160

    authors: Bernier A,Cleret-Buhot A,Zhang Y,Goulet JP,Monteiro P,Gosselin A,DaFonseca S,Wacleche VS,Jenabian MA,Routy JP,Tremblay C,Ancuta P

    更新日期:2013-12-21 00:00:00

  • Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines.

    abstract::Correlates of protection (CoPs) against infection by primate lentiviruses remain undefined. Modest protection against HIV-1 was observed in one human vaccine trial, whereas previous trials and vaccine-challenge experiments in non-human primates have yielded inconsistent but intriguing results. Although high levels of ...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-9-80

    authors: Klasse PJ,Moore JP

    更新日期:2012-10-01 00:00:00

  • Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

    abstract:BACKGROUND:The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection is important, particularly as it can be vertically transmitted by breast feeding mothers to their infants. However, current diagnosis in Japan requires a confirmatory western blot (WB) test after screening/primary testing for HTL...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-020-00534-0

    authors: Okuma K,Kuramitsu M,Niwa T,Taniguchi T,Masaki Y,Ueda G,Matsumoto C,Sobata R,Sagara Y,Nakamura H,Satake M,Miura K,Fuchi N,Masuzaki H,Okayama A,Umeki K,Yamano Y,Sato T,Iwanaga M,Uchimaru K,Nakashima M,Utsunomiya A

    更新日期:2020-08-24 00:00:00

  • MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.

    abstract:BACKGROUND:Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to be highly conserved ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-36

    authors: Grupping K,Selhorst P,Michiels J,Vereecken K,Heyndrickx L,Kessler P,Vanham G,Martin L,Ariën KK

    更新日期:2012-05-02 00:00:00

  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.

    abstract:BACKGROUND:Mutations in the substrate of HIV-1 protease, especially changes in the NC/p1 cleavage site, can directly contribute to protease inhibitor (PI) resistance and also compensate for defects in viral replicative capacity (RC) due to a drug resistant protease. These NC/p1 changes are known to enhance processing o...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-29

    authors: van Maarseveen NM,Andersson D,Lepšík M,Fun A,Schipper PJ,de Jong D,Boucher CA,Nijhuis M

    更新日期:2012-04-01 00:00:00

  • Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.

    abstract::We have obtained the 1.7 A crystal structure of FIV protease (PR) in which 12 critical residues around the active site have been substituted with the structurally equivalent residues of HIV PR (12X FIV PR). The chimeric PR was crystallized in complex with the broad-based inhibitor TL-3, which inhibits wild type FIV an...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-4-1

    authors: Heaslet H,Lin YC,Tam K,Torbett BE,Elder JH,Stout CD

    更新日期:2007-01-09 00:00:00

  • The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.

    abstract:BACKGROUND:HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to chemo-resistance and immuno-compromised micro-environment. The combination of zidovudine and interferon-alpha (IFN) significantly improved survival in ATL. Promising results were reported by adding arsenic trioxide to zi...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-91

    authors: Kchour G,Rezaee R,Farid R,Ghantous A,Rafatpanah H,Tarhini M,Kooshyar MM,El Hajj H,Berry F,Mortada M,Nasser R,Shirdel A,Dassouki Z,Ezzedine M,Rahimi H,Ghavamzadeh A,de Thé H,Hermine O,Mahmoudi M,Bazarbachi A

    更新日期:2013-08-20 00:00:00

  • Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada.

    abstract::The 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses was held in Montreal, Québec from June 26th to June 30th, 2013 and was therefore hosted by a Canadian city for the first time. The major topic of the meeting was human T-lymphotropic viruses (HTLVs) and was covered through distinct...

    journal_title:Retrovirology

    pub_type:

    doi:10.1186/1742-4690-11-19

    authors: Barbeau B,Hiscott J,Bazarbachi A,Carvalho E,Jones K,Martin F,Matsuoka M,Murphy EL,Ratner L,Switzer WM,Watanabe T

    更新日期:2014-02-24 00:00:00

  • Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site.

    abstract:BACKGROUND:Retroviruses have a diploid genome and recombine at high frequency. Recombinant proviruses can be generated when two genetically different RNA genomes are packaged into the same retroviral particle. It was shown in several studies that recombinant proviruses could be generated in each round of HIV-1 replicat...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-2-3

    authors: Kharytonchyk SA,Kireyeva AI,Osipovich AB,Fomin IK

    更新日期:2005-01-18 00:00:00

  • Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.

    abstract:BACKGROUND:Regulatory T cells (Tregs) have been shown to limit anti-viral immunity during chronic retroviral infection and to restrict vaccine-induced T cell responses. The objective of the study was to assess whether a combinational therapy of nanoparticle-based therapeutic vaccination and concomitant transient ablati...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/s12977-016-0258-9

    authors: Knuschke T,Rotan O,Bayer W,Sokolova V,Hansen W,Sparwasser T,Dittmer U,Epple M,Buer J,Westendorf AM

    更新日期:2016-04-14 00:00:00